CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs

Similar documents
1. PROCEDURE FOR THIS INVITATION TO EOI 2. APIS INCLUDED IN THE 14TH INVITATION. Guidance Document 11 April 2017

Monographs on ARV and hepatitis medicines in The International Pharmacopoeia

1. Procedure for this Invitation to EOI. 2. Medicinal products included on the 14 th Invitation. Guidance Document 14 May 2016

Invitation to Manufacturers 16 August 2017

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and

Chapter 5 ~ Infections

The International Pharmacopoeia - Overview

poor solubility and poor permeability unknown whether poor BA is due to poor solubility or antiglaucoma medicine for biowaiver Not eligible

Appendix 5: Hepatic impairment

WHO Model List (revised April 2002)

Il programma dei farmaci essenziali dell OMS, la nuova lista marzo Suzanne Hill Department of Medicines Policy and Standards WHO

Medicines recommended to prevent and manage the priority diseases at the community and health facility level

Prequalification Programme Bioequivalence Assessment Update. Dr. John Gordon

The Global Health Impact Index

Appendix 4: Renal impairment

Priority essential medicines: identifying products. Dr Suzanne Hill September 2010

REIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO

Compendium of Notified Ceiling Prices NLEM 2015

WEB ANNEX J. TABLE OF DRUG INTERACTIONS WITH ANTIRETROVIRAL DRUGS

COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH

EML 14 COMPLEMENTARY LIST

Recommended Comparator Products: Medicines for HIV/AIDS and Related Diseases

Appendix 1: Interactions

Hospital Pharmaceuticals Review PTAC, Hospital Pharmaceuticals Subcommittee & Anti-Infective Subcommittee minutes for web publishing

LIST OF ESSENTIAL MEDICINES OF RA

Antimalarials in the WHO Essential Drugs List for Children Reviewer No.1

104 MMWR December 17, 2004

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS

Essential Medicines 15th edition (March 2007) WHO Model List (revised March 2007)

Antiretroviral Dosing in Renal Impairment

WHO Model List of Essential Medicines

WHO Model List of Essential Medicines

Category and Product-level Procurement and Delivery Planning Guide

(To be Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary)

WHO Model List of Essential Medicines

PROGRAM General Information

WHO Model List of Essential Medicines

Ministry of Health, Pharmacy Division STOCK STATUS REPORT AS AT NOVEMBER 1st 2013

Sources and Prices of Medicines for Children.

List of changes in Out-Patients Formulary

REVIEW No Assessment of safety a. Have all relevant studies on safety been included Yes X No (if no, please provide reference and information)

Drug Treatment Program Update

Inventory of paediatric therapeutic needs

ALABAMA S ADAP FORMULARY OFFERS 117 MEDICATIONS

WHO Technical Report Series The Selection and Use of Essential Medicines

List of Optimal Paediatric Formulations. Marianne Gauval (CHAI) IAS-ILF Round table Geneva, Switzerland 26 November 2013

MEDICINES CATALOG NOVEMBER 2018 GLOBAL DRUG FACILITY (GDF)

Concomitant antiretroviral therapy : Avifanz must be given in combination with other antiretroviral medications.

Industry Data Request

First DRAFT: WHO Model List of Essential Medicines for Children Explanatory notes

WHO Model List of Essential Medicines for Children Explanatory Notes

FIXED DOSE COMBINATION: CLINICAL & PHARMACEUTICAL PERSPECTIVES

FORMULARY Virginia (VA) AIDS Drug Assistance Program (ADAP) LAST UPDATED: December At a Glance: VA ADAP Formulary

GPRM - Global Price Reporting Mechanism November Transaction prices for Antiretroviral Medicines and HIV Diagnostics from 2008 to October 2009

WHO Model List of Essential Medicines for Children

WESTERN CAPE ART GUIDELINES PRESENTATION 2013

Drug Development by Government Pharmaceutical Organization. Dr. Rachaneekorn Jevprasesphant The Government Pharmaceutical Organization (GPO) Thailand

CEFACLOR Non Formulary 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins

Appropriate Use & Safety Edits

Syria Essential Drugs List (EDL) Priority 2014

The Global Health Impact Index. Company Report

Thank you for your request for information that has been processed under reference number

WOMENS INTERAGENCY HIV STUDY ANTIRETROVIRAL DOSAGE FORM SECTION A. GENERAL INFORMATION

The International Pharmacopoeia

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily

WHO Model List of Essential Medicines for Children

SUMMARY OF PRODUCT CHARACTERISTICS. Excipient with known effect: Darunavir Alvogen 400 mg: Each tablet contains mg sunset yellow FCF (E110).

PRODUCT LIST GENERAL - TABLETS

Toolkit on monitoring health systems strengthening MEDICAL PRODUCTS, VACCINES AND TECHNOLOGIES

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

THE INTERAGENCY EMERGENCY HEALTH KIT SVIZERA EUROPE BV

Chapter 4 ~ Central nervous system

The Hospitalized HIV+ Patient

Rajasthan Medical Services Corporation Limited, Jaipur

SUMMARY OF PRODUCT CHARACTERISTICS

Box 1. Recommendations unchanged from the first edition of the Guidelines (2006)

SUMMARY OF PRODUCT CHARACTERISTICS

Medicines Formulary BNF Section 4 Central Nervous System

HIV in the Brain MANAGING COMORBIDITIES IN PATIENTS WITH HIV

Combination Anti-malarial Therapy and WHO Recommendations

nevirapine, zidovudine and lamivudine

Ministry of Health, Pharmacy Division STOCK STATUS REPORT AS AT 1 JULY 2013

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

EML- ANTIRETROVIRALS INTERACTIONS TABLE

Elizabeta Zisovska, Skopje, Republic of Macedonia

CHILDREN S MEDICINES IN UGANDA

PHARMACOKINETICS OF ANTIRETROVIRAL AND ANTI-HCV AGENTS

Daclatasvir (Daklinza ) Drug Interactions with HIV Medications

APRIL Key Findings: Overall. Key Findings: Availability

reductions Untangling the web of price reductions: eligibility pricecountries company price countries price

Recommended comparator products: Medicines for HIV/AIDS and related diseases

Supplier/ Manufacturer(s) Unit III, Survey No 51, Plot No IDA, Jeedimetla, Hyderabad, Telangana, Hetero labs limited

Strategic Fund Medicine List / Lista de Medicamentos del Fondo Estratégico 1 Updated September

THE HIV LIFE CYCLE. Understanding How Antiretroviral Medications Work

reductions Untangling the web of price reductions: 6th Edition eligibility pricecountries company price countries price

Summary of the Report as of 1st February 2017

Transcription:

page 1 CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs 2011 The following categories are included in this work programme: 1. Medicines used in HIV/AIDS treatment (antiretrovirals - ARVs) 2. Medicines used in malaria treatment 3. Medicines used in TB treatment 4. Anti-infectives (antibacterials, antiprotozoal, antifungal, antiviral, and antimycobacterial agents, anthelmintics) 5. Oral rehydration therapy 6. Other medicines (other antivirals, analgesics, antipyretics, palliative care agents, anti-epileptics, large volume parenterals, reproductive health, vitamins, cytotoxic agents, insulins) Entries highlighted in red correspond to new additions. Where a draft monograph has already been provided to the Secretariat for discussion, this is indicated by means of the symbol *.

page 2 1. Medicines used in HIV/AIDS treatment (antiretrovirals - ARVs) : Atazanavir : Emtricitabine oral solution Ritonavir capsules Ritonavir oral solution Stavudine powder for oral solution Zidovudine tablets Atazanavir capsules Fixed-dose combinations (FDC): Tenofovir and lamivudine tablets Tenofovir, efavirenz and lamivudine tablets Atazanavir and ritonavir tablets Lamivudine and abacavir tablets Lamivudine, abacavir and nevirapine tablets Lopinavir and ritonavir capsules Lopinavir and ritonavir oral solution Lamivudine and stavudine tablets Lamivudine, stavudine and nevirapine tablets, as available for: Lamivudine + Zidovudine + Efavirenz** ** to confirm with the Disease Programme

page 3 2. Medicines used in Malaria treatment Piperaquine phosphate Artesunate rectal capsules Fixed-dose combinations (FDC): Artemether and lumefantrine capsules Artemether and lumefantrine dispersible tablets Artesunate and amodiaquine tablets Dihydroartemisinin and piperaquine phosphate tablets Revision Artemisinin derivatives ( and dosage forms) (see http://www.who.int/medicines/publications/pharmacopoeia/mon_mal/en/index.html)

page 4 3. Medicines used in Tuberculosis (TB) treatment : Moxifloxacin p-aminosalicylic acid Terizidone : Moxifloxacin tablets/capsules Ethambutol oral liquid Pyrazinamide oral syrup p-aminosalicylic acid granules Ethionamide tablets/capsules Protionamide tablets Terizidone tablets/capsules

page 5 4. Anti-infectives (antibacterials, antiprotozoals, antifungals, antivirals, anthelminthics and antimycobacterial agents) Azithromycin Aciclovir Cefixime Rifabutin Ceftriaxone sodium Fluconazole Ivermectin Azithromycin capsules Azithromycin oral liquid Sulfadiazine tablets Clindamycin capsules Clindamycin injection Clindamycin oral liquid Aciclovir tablets Aciclovir powder for injection Aciclovir oral liquid Spectinomycin powder for injection Cefixime capsules Rifabutin capsules Albendazole chewable tablets Ceftriaxone injection Doxycycline dispersible tablets Fluconazole capsules Fluconazole injection Fluconazole oral solution/suspension Ivermectin tablets Pyrantel chewable tablets* Pyrantel oral solution* Pyrimethamine tablets Fixed-dose combinations (FDC): Sulfamethoxazole and trimethoprim injection Sulfamethoxazole and trimethoprim oral solution/suspension

page 6 5. Oral rehydration therapy Zinc acetate Zinc gluconate Paediatric zinc acetate tablets Paediatric zinc acetate oral solution Paediatric zinc gluconate oral solution Paediatric zinc gluconate tablets

page 7 6. Other medicines (other antivirals, analgesics, antipyretics, palliative care agents, anti-epileptics, LVPs 1, reproductive health, vitamins, cytotoxic agents, insulins) Morphine oral solution Paediatric Retinol oral solution Antiepileptics Carbamazepine oral liquid Carbamazepine chewable tablets Phenobarbital oral liquid Phenytoin oral liquid Phenytoin chewable tablets Valproic acid oral liquid Valproic acid crushable tablets Large volume parenterals Glucose intravenous infusion Sodium chloride intravenous infusion Sodium chloride and glucose intravenous infusion Reproductive health Mifepristone Misoprostol Norgestrel Mifepristone tablets Misoprostol tablets Norgestrel tablets Norethisterone tablets Norethisterone injection Note from Secretariat: used in co-blisters with Misoprostol tablets Ethinylestradiol + levonorgestrel tablets Medroxyprogesterone acetate (DMPA), depot injection 1 LVPs: Large Volume Parenterals

page 8 Cytotoxic medicines Bleomycin powder for injection Etoposide capsules Vinblastine powder for injection Vincristine powder for injection Calcium folinate tablets Calcium folinate injection Insulins Insulin, human Insulin, bovine Insulin, porcine Insulin preparations - General monograph Insulin injection (soluble) Insulin zinc suspension Isophane insulin injection Insulin zinc suspension (amorphous)** Insulin zinc suspension (crystalline)** Biphasic insulin injection** Biphasic isophane insulin injection ** Protamine zinc insulin injection** ** to confirm with the Disease Programme ***